The Drug Enforcement Administration (DEA) Philadelphia Field Division (PFD) Intelligence Program maintains situational awareness of drug availability, abuse, trafficking patterns, adulterants, concealment methods, etc., through analysis of law enforcement and public health information and data, as well as law enforcement source information.

The Drug Enforcement Administration (DEA) Philadelphia Field Division (PFD) conducted a review of laboratory-analyzed drug seizures for the Commonwealth of Pennsylvania. The resulting analysis of this data formed the basis for estimating the level of drug presence in Pennsylvania and highlighted trends in drug availability between 1999 and 2016.

The Drug Enforcement Administration (DEA) Philadelphia Field Division (PFD) conducted an assessment of laboratory-analyzed drug seizures. Some seized cocaine exhibits were found to contain cocaine and fentanyl, as well as a combined cocaine and fentanyl presence in overdose death toxicology reporting. This analysis was conducted in response to reported increases...

The Domestic Methamphetamine Threat Assessment provides a comprehensive strategic assessment of the threat posed to the United States by the trafficking and use of methamphetamine. This report combines federal, state, and local law enforcement reporting; public health data; news reports; and intelligence from other government agencies to assess the methamphetamine...

The Drug Enforcement Administration’s (DEA) Heroin Domestic Monitor Program (HDMP) is a retail-level heroin purchase program that provides data analysis about the geographic source of heroin, along with price, purity, adulterants, and diluents sold at the street-level in 27 U.S. cities. In 2015, a total of 823 qualified exhibits were...

The 2017 National Drug Threat Assessment (NDTA)1 is a comprehensive strategic assessment of the threat posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. The report combines federal, state, local and tribal law enforcement reporting; public health data; open source reporting; and...

The Drug Enforcement Administration’s (DEA) Heroin Signature Program (HSP) analyzes several hundred wholesale-level heroin samples each year to identify the geographic area—Mexico, South America (SA), Southwest Asia (SWA), or Southeast Asia (SEA)—where the samples were manufactured.

Changes in key international cocaine market indicators point to the highest U.S. cocaine supply levels since at least 2007. National data also show the most significant increase in domestic cocaine usage since at least 2009. Recent cocaine production and U.S. Transit Zone movement indicators have reached the highest levels ever...

The King County Medical Examiner’s Office (KCMEO) reported that deaths caused by drugs increased to their highest levels in 2016 in King County, Washington. Methamphetamine was responsible for 109 (30 percent) of the 360 drug deaths according to KCMEO data. DEA reporting indicates that the methamphetamine responsible for the overdose...

A recent enforcement operation by the Drug Enforcement Administration’s (DEA) Indianapolis District Office (IDO) resulted in the seizure of 970 purported prescription pills that were various shades of blue and appeared to be oxycodone. Laboratory analysis subsequently revealed that the pills were counterfeit; the dark blue pills contained carfentanil and...